Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
5 hedge funds and large institutions have $14.7M invested in Abeona Therapeutics Inc Warrant in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
15% less capital invested
Capital invested by funds: $17.3M → $14.7M (-$2.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFG
OTA Financial Group
Purchase,
New York
|
+$355K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.44K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $12M | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $2.43M | – | – | – |
|
|
OFG
3
OTA Financial Group
Purchase,
New York
| $338K | +$355K | +35,584 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | +$2.44K | +245 | New |
|
5
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
ABEOW Hedge Fund Activity: Q1 2018 in Review
5 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q1 2018, worth a combined $14.7M — down 15% from $17.3M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ABEOW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OTA Financial Group, opening a new position worth an estimated $355K.
- 5 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q1 2018, up from 3 in Q4 2017.
- Funds reported $14.7M of Abeona Therapeutics Inc Warrant stock for Q1 2018, down 15% quarter-over-quarter.
- 2 funds opened new Abeona Therapeutics Inc Warrant positions in Q1 2018 and 0 closed out, a net change of +2 holders.
- The largest Abeona Therapeutics Inc Warrant buyer in Q1 2018 was OTA Financial Group, an estimated $355K added.
Based on aggregated 13F filings for Q1 2018.